March 10, 2009 – As early detection increases for peripheral arterial disease (PAD) and more patients seek treatment, the U.S. market for peripheral vascular treatment will grow to an estimated $4.7 billion by 2015, according to iData Research, an international medical device & dental market research firm.
Currently, of the estimated 10 million people in the U.S. who suffer from lower limb Peripheral Arterial Disease (PAD), 80 percent go undiagnosed, the study revealed.
PAD is the formation of plaque in arterial blood vessels of the outer circulatory system that causes damage to the arterial wall, which in turn increases the risk of stroke. In 2008, over 4 million individuals in the U.S. had symptoms indicative of PAD, such as persistent leg cramping, numbness, fatigue and severe pain.
"Of people aged 50 to 69 with a history of smoking or diabetes, approximately 30 percent will manifest PAD," says Kamran Zamanian, Ph.D., CEO of iData Research, "This will drive sales for PAD treatment devices, particularly for devices such as stents and stent-grafts, and complementary and alternative products, like embolic protection and atherectomy devices."
In 2008, the largest segment in the U.S. market for peripheral vascular devices was for stents, which represented 28.7 percent of the overall treatment market. The stent market will grow at double digit rates through 2015, led by an increase in early diagnoses. The U.S. government and the medical community have taken an active role in improving awareness of PAD among physicians and the general population.
For more information: www.idataresearch.net